Trader sentiment strongly favors no new coronavirus pandemic in 2026, reflected in the 94.5% market-implied probability for that outcome. This consensus stems from ongoing global genomic surveillance showing SARS-CoV-2 circulation remains endemic, with current variants lacking the dual traits of markedly higher transmissibility and immune escape needed for widespread resurgence. High population immunity from repeated infections and updated vaccines continues to limit severe disease, keeping hospitalization rates stable according to public health monitoring. While recombination events could theoretically yield a more virulent strain, historical patterns since 2020 indicate gradual evolution rather than sudden shifts capable of pandemic ignition. Routine sequencing programs and case-threshold tracking provide early signals, with any anomalous spike likely to prompt swift market reassessment before year-end.